Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Myélomes
- | Specialty :
- Thérapies Ciblées
Extract
An open-label, phase Ib, dose-escalation study of the safety and pharmacology of the anti-CD40 monoclonal antibody SGN-40 administered in combination with bortezomib (Velcade®, PS-341) in patients with relapsed or refractory multiple myeloma.
Scientific Abstract
en cours d'intégration;